US State price-setting boards create more questions than answers

American States are rolling out complex drug price-setting efforts - but there is no evidence yet that patients are or will save money at the pharmacy counter, according to trade group Pharmaceutical Research Manufacturers of America (PhRMA).

Long-time supporters of state government price-setting and prescription drug board members themselves are raising concerns about how these policies are playing out and whether patients will benefit or if such policies will make it harder for patients to get their medicines.